Dr Haydon DuMond
Senior Manager, Medical Affairs

About

Haydon DuMond, PharmD, is Senior Manager, Medical Affairs at Enable Injections. He earned his Doctor of Pharmacy from Purdue University, practising across community and specialty pharmacy before moving into pharmaceutical medical affairs. His work spans evidence generation, global KOL engagement, and translating clinical and scientific data into communications for healthcare providers.

Contributions

WEARABLES

THE PERCEPTION PROBLEM WITH SC VOLUME LIMITS AND ITS DRUG DEVELOPMENT COST

Dr Haydon DuMond, Dr Mehul Desai, along with Dr Shirish Ingawale, examine survey evidence and regulatory precedent showing that the widely cited 2–3 mL limit on subcutaneous delivery reflects device history and information habits rather than tissue biology, and consider the consequences for formulation strategy, device selection and the growing pipeline of large-volume subcutaneous therapies.